Drug Information Association Logo

Safety Audits and Inspections

| Online

« Back to Listing


Module 6 Scheduled Launch Date: October 2014

Drug safety affects everyone involved in the pharmaceutical product lifecycle. The DIA Drug Safety eLearning Program will provide a broad overview of safety regulations, requirements and activities throughout the product lifecycle from clinical trials, approval, to postmarketing activities.  This program is designed for professionals involved in drug safety and pharmacovigilance, clinical research, marketing approval, and postmarketing activities.  It will also benefit anyone working in related fields including regulatory affairs, clinical development, medical affairs, and quality assurance/compliance, who would like to enhance their knowledge and understanding of drug safety.

Featured Topics 

  • Types and Scope of Audits and Inspections
  • Common Inspection Findings
  • Responding to an Inspection
  • Corrective and Preventive Action Plan

Who Should Attend 

Professionals working in the area of:

  • Drug safety & pharmacovigilance
  • Clinical research and development
  • Marketing approval
  • Postmarketing activities
  • Regulatory and medical affairs
  • Quality assurance/compliance
  • Anyone who would like to enhance their knowledge and understanding of drug safety

Special Offers 

Buy all six modules and Save 20%!

Contact Information 

Linda Belmont, DIA
Phone +

Technical Requirements 

Click here for minimum system requirements.

Registration Fees 

Other Fees

Group Discounts

When purchasing modules from the DIA Drug Safety eLearning Program:

  • Purchase 2-5 modules and receive a 10% discount on each item
  • Purchase 6 modules and receive a 20% discount on each item

Register Online

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

« Back to Listing Back To Top